* AMN Healthcare Services Inc AMN.N AMN is expected
to show a
fall in quarterly revenue when it reports results on May 4.
* The Dallas Texas-based company is expected to report a
28.3% decrease in revenue to $1.113 billion from $1.55 billion a
year ago, according to the mean estimate from 7 analysts, based
on Refinitiv data. The company's guidance on February 16 2023,
for the period ended March 31, was for revenue between 1.10
billion and 1.13 billion.
* Refinitiv's mean analyst estimate for AMN Healthcare
Services
Inc is for earnings of $2.36 per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had risen by
about 0.1%
in the last three months.
* Wall Street's median 12-month price target for AMN
Healthcare
Services Inc is $128, above its last closing price of $83.95.
The company's guidance on February 16 2023 for the period ended
March 31 was for Earnings before Interest and Taxes between 121
million and 132.21 million.The company's guidance on February 16
2023 for the period ended March 31 was for Earnings before
Interest, Taxes, Depreciation and Amortization of between 1.1
billion and 179.67 million.The company's guidance on February 16
2023 for the period ended March 31 was for gross profit margin
between 32.6% and 33.1%.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 2.19 2.14 2.48 Beat 15.9
Sep. 30 2022 2.39 2.37 2.57 Beat 8.5
Jun. 30 2022 2.99 2.97 3.31 Beat 11.6
Mar. 31 2022 3.22 3.20 3.49 Beat 9
Dec. 2.77 2.66 2.95 Beat 11.1
31 2021
Sep. 30 2021 1.31 1.30 1.73 Beat 32.7
Jun. 30 2021 1.43 1.43 1.64 Beat 14.9
Mar. 31 2021 1.37 1.37 1.70 Beat 24.3
This summary was machine generated May 3 at 02:01 GMT. All
figures in US dollars unless otherwise stated